全文获取类型
收费全文 | 2445篇 |
免费 | 28篇 |
专业分类
电工技术 | 4篇 |
综合类 | 54篇 |
化学工业 | 114篇 |
金属工艺 | 3篇 |
机械仪表 | 15篇 |
建筑科学 | 66篇 |
矿业工程 | 1篇 |
能源动力 | 16篇 |
轻工业 | 40篇 |
水利工程 | 4篇 |
石油天然气 | 1篇 |
无线电 | 94篇 |
一般工业技术 | 96篇 |
冶金工业 | 1824篇 |
原子能技术 | 8篇 |
自动化技术 | 133篇 |
出版年
2020年 | 8篇 |
2019年 | 5篇 |
2018年 | 10篇 |
2016年 | 6篇 |
2015年 | 15篇 |
2014年 | 25篇 |
2013年 | 47篇 |
2012年 | 47篇 |
2011年 | 35篇 |
2010年 | 30篇 |
2009年 | 36篇 |
2008年 | 49篇 |
2007年 | 34篇 |
2006年 | 22篇 |
2005年 | 21篇 |
2004年 | 23篇 |
2003年 | 27篇 |
2002年 | 13篇 |
2001年 | 21篇 |
2000年 | 14篇 |
1999年 | 63篇 |
1998年 | 494篇 |
1997年 | 286篇 |
1996年 | 191篇 |
1995年 | 123篇 |
1994年 | 99篇 |
1993年 | 119篇 |
1992年 | 21篇 |
1991年 | 37篇 |
1990年 | 40篇 |
1989年 | 41篇 |
1988年 | 37篇 |
1987年 | 40篇 |
1986年 | 28篇 |
1985年 | 29篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1982年 | 10篇 |
1981年 | 18篇 |
1980年 | 18篇 |
1979年 | 8篇 |
1978年 | 20篇 |
1977年 | 39篇 |
1976年 | 105篇 |
1975年 | 15篇 |
1974年 | 8篇 |
1973年 | 10篇 |
1971年 | 8篇 |
1970年 | 6篇 |
1968年 | 5篇 |
排序方式: 共有2473条查询结果,搜索用时 15 毫秒
101.
CS Zent CS Wilson G Tricot S Jagannath D Siegel KR Desikan N Munshi D Bracy B Barlogie AW Butch 《Canadian Metallurgical Quarterly》1998,91(9):3518-3523
Multiple myeloma (MM) is usually characterized by production of a single serum monoclonal protein of constant isotype and light-chain restriction. Multiple Ig isotypes and isotype switches, which are rare in untreated patients, are reported to be more common in patients undergoing myeloablative therapy. These additional protein bands, detected by immunofixation electrophoresis (IFE), could be due to altered paraprotein production by the malignant plasma cell clone or oligoclonal Ig production during recovery of B-cell function after myeloablative therapy. We analyzed abnormal protein bands (APB), distinct from the presenting paraprotein, in 550 patients receiving high-dose therapy with autologous hematopoietic cell transplantation at a single institution. Fifty-five patients (10%) had APB, 48 had oligoclonal bands (OB), and 23 had an apparent isotype switch (IS) on IFE (16 had both OB and IS). Morphologic and flow cytometric examination of bone marrow in 17 patients with IS showed no evidence of a clonal plasma cell isotype switch. Patients with APB had significantly higher complete response to therapy (67% v 37%, P = .001). To assess the independent prognostic relevance of APB, a multivariate analysis was performed among 471 patients surviving at least 12 months from first transplant (all patients developing APB had done so by 12 months from first transplant). APB (in 50 patients) was a favorable feature for both event-free (rank 3, P = .004) and overall survival (rank 3, P = .0005). We propose that OB and IS are likely to be due to recovery of Ig production rather than alterations in the biology of the malignant plasma cell clone. 相似文献
102.
DC Underwood S Bochnowicz RR Osborn CJ Kotzer MA Luttmann DW Hay PD Gorycki SB Christensen TJ Torphy 《Canadian Metallurgical Quarterly》1998,287(3):988-995
We evaluated the airway activity of the novel phosphodiesterase type 4 inhibitor SB 207499 [Ariflo; c-4-cyano-4-(3-cyclopentyloxy-4-methoxyp henyl-r-1-cyclohexane carboxylic acid)], in the guinea pig. Ovalbumin (OA)-induced contractions of guinea pig isolated tracheal strips were inhibited by SB 207499 with an EC50 of 1 microM but had little or no effect on exogenous agonist-induced contraction, which suggests that its effect on OA-induced contraction in vitro is primarily due to inhibition of mediator release from mast cells. In anesthetized guinea pigs, SB 207499 inhibited OA-induced bronchoconstriction with i.v. and p.o. ID50 values of 1.7 and 17 mg/kg, respectively. At 1, 3 and 6 hr after SB 207499 (30 mg/kg p.o.), OA-induced bronchospasm was inhibited by 92%, 70% and 58%, respectively, corresponding to elevated plasma concentrations of 1.62 +/- 0.19, 1.65 +/- 0.29 and 0. 93 +/- 0.24 microg/ml, respectively, of SB 207499. SB 207499 also inhibited house dust mite-induced bronchoconstriction (ID50 = 0.9 mg/kg i.v. and 8.9 mg/kg p.o.). In contrast to its lack of bronchorelaxant activity in vitro, SB 207499 inhibited bronchospasm induced by i.v. leukotriene D4 (LTD4) [ID50 = 3 mg/kg i.v.]. The bronchorelaxant effect of i.v.-administered SB 207499 was at least additive with that of salbutamol in reversing infused histamine-enhanced airway tone, but it did not alter base line or enhance salbutamol-induced cardiovascular effects. In conscious guinea pigs, SB 207499 (10 or 30 mg/kg p.o.), 1 hr before antigen or LTD4 challenge, markedly reduced bronchospasm and subsequent eosinophil influx as measured by bronchoalveolar lavage 24 hr after provocation. SB 207499 administered after OA or LTD4 challenge also reduced airway eosinophilia measured at 24 hr after OA challenge or 96 hr after LTD4 challenge. These results, coupled with the broad anti-inflammatory activity of SB 207499 previously described (Barnett et al., 1998), suggest that SB 207499 will be useful in the treatment of asthma and other inflammatory disorders. 相似文献
103.
MD de Jong GJ Galasso B Gazzard PD Griffiths DA Jabs ER Kern SA Spector 《Canadian Metallurgical Quarterly》1998,39(3):141-162
Human cytomegalovirus (HCMV) is a highly species-specific DNA virus belonging to the Betaherpesvirinae subfamily of the herpesviridae family. Like other herpesviruses, primary infection with HCMV is followed by persistence of the virus in a latent form. The sites of latency are still largely undefined, but they probably include bone marrow progenitor cells and peripheral blood monocytes. From these sites, the virus can reactivate, resulting in renewed shedding of the virus, or, in immunocompromized persons, development of disease. Humans are the only reservoir of HCMV and transmission occurs by person-to-person contact. Infection with HCMV is common. In most developed countries, HCMV seroprevalence steadily increases after infancy and 10-20% of children are infected before puberty. In adults, the prevalence of antibodies ranges from 40 to 100%. Although HCMV has a world-wide distribution, infection with HCMV is more common in the developing countries and in areas of low socioeconomic conditions, which is predominantly related to the closeness of contacts within these populations. Except for a mononucleosis-like illness in some persons, infection with HCMV rarely causes disease in immunocompetent individuals. However, HCMV can cause severe morbidity and mortality in congenitally infected newborns and immunocompromized patients, most notably transplant-recipients and HIV-infected persons. This article provides a review of the information presented at the Second International Symposium on Cytomegalovirus organized and convened by The Macrae Group (New York City, NY) in Acapulco, Mexico on 24-28 April 1998. During this symposium, the state-of-the-art knowledge on diagnosis, treatment and prophylaxis of HCMV infections were discussed, and, based on this information, attempts to highlight the future directions in basic and clinical research areas that need to be stimulated to facilitate advancement in prevention and treatment of CMV disease. 相似文献
104.
IM Bell JM Erb RM Freidinger SN Gallicchio JP Guare MT Guidotti RA Halpin DW Hobbs CF Homnick MS Kuo EV Lis DJ Mathre SR Michelson JM Pawluczyk DJ Pettibone DR Reiss S Vickers PD Williams CJ Woyden 《Canadian Metallurgical Quarterly》1998,41(12):2146-2163
The previously reported oxytocin antagonist L-371,257 (2) has been modified at its acetylpiperidine terminus to incorporate various pyridine N-oxide groups. This modification has led to the identification of compounds with improved pharmacokinetics and excellent oral bioavailability. The pyridine N-oxide series is exemplified by L-372,662 (30), which possessed good potency in vitro (Ki = 4.1 nM, cloned human oxytocin receptor) and in vivo (intravenous AD50 = 0.71 mg/kg in the rat), excellent oral bioavailability (90% in the rat, 96% in the dog), good aqueous solubility (>8.5 mg/mL at pH 5.2) which should facilitate formulation for iv administration, and excellent selectivity against the human arginine vasopressin receptors. Incorporation of a 5-fluoro substituent on the central benzoyl ring of this class of oxytocin antagonists enhanced in vitro and in vivo potency but was detrimental to the pharmacokinetic profiles of these compounds. Although lipophilic substitution around the pyridine ring of compound 30 gave higher affinity in vitro, such substituents were a metabolic liability and caused shortfalls in vivo. Two approaches to prevent this metabolism, addition of a cyclic constraint and incorporation of trifluoromethyl groups, were examined. The former approach was ineffective because of metabolic hydroxylation on the constrained ring system, whereas the latter showed improvement in plasma pharmacokinetics in some cases. 相似文献
105.
106.
Hematocrits (PCV) were measured at 29 and 106 d of age (PCV1 and PCV2, respectively) in male and female White Plymouth Rocks. Four lines were used, two of which had undergone 40 generations of divergent selection for 8-wk BW (HWS, LWS), and two respective sublines (HWR, LWR), in which selection had been relaxed for five generations. At both ages, males and females did not differ for PCV in lines HWR, LWR, and LWS. For line HWS there was an age by sex interaction that resulted from an age effect for males but not for females, and from a sex effect at each age. At both ages, PCV was higher for the HW than the LW lines. Initially, there was no difference between the selected and their respective relaxed lines, but by 106 d, HWR chickens had a higher PCV than HWS chickens. In lines HWR and LWR, PCV increased with age. There was a negative correlation in HWS males for PCV1 with 28 and 56 d BW. The HWR males also had a negative correlation for PCV1 with BW at 28 d, but not between PCV2 and BW. The correlation for PCV1 with PCV2 was high and positive for HWR males and females. 相似文献
107.
Siegel P.H. Dengler R.J. Mehdi I. Oswald J.E. Bishop W.L. Crowe T.W. Mattauch R.J. 《Microwave Theory and Techniques》1993,41(11):1913-1921
This paper presents design and performance data for a 215-GHz subharmonically pumped waveguide mixer using an antiparallel-pair of planar air-bridge-type GaAs Schottky-barrier diodes. The waveguide design is a prototype for a 640-GHz system and uses split-block rectangular waveguide with a 2:1 width-to-height ratio throughout. The measured mixer noise and conversion loss are below that of the best reported whisker contacted or planar-diode mixers using the subharmonic-pump configuration at this frequency. In addition, the required local oscillator power is as low as 3 mW for the unbiased diode pair, and greater than 34 dB of LO noise suppression is observed. Separate sideband calibration, using a Fabry-Perot filter, indicates that the mixer can be tuned for true double sideband response at an intermediate frequency of 1.5 GHz. Microwave scale model measurements of the waveguide mount impedances are combined with a mixer nonlinear analysis computer program to predict the mixer performance as a function of anode diameter, anode finger inductance, and pad-to-pad fringing capacitance. The computed results are in qualitative agreement with measurements, and indicate that careful optimization of all three diode parameters is necessary to significantly improve the mixer performance 相似文献
108.
AI Qureshi JI Suarez PD Parekh G Sung R Geocadin A Bhardwaj RJ Tamargo JA Ulatowski 《Canadian Metallurgical Quarterly》1998,43(1):22-6; discussion 26-7
OBJECTIVE: Risk factors that predispose to the formation of multiple intracranial aneurysms, which are present in up to 34% of patients with intracranial aneurysms, are not well defined. In this study, we examined the association between known risk factors for cerebrovascular disease and presence of multiple intracranial aneurysms. METHODS: We reviewed the medical records and results of conventional angiography in all patients with a diagnosis of intracranial aneurysms admitted to the Johns Hopkins University hospital between January 1990 and June 1997. We determined the independent association between various cerebrovascular risk factors and the presence of multiple aneurysms using logistic regression analysis. RESULTS: Of 419 patients admitted with intracranial aneurysms (298 ruptured and 121 unruptured), 127 (30%) had multiple intracranial aneurysms. In univariate analysis, female gender (odds ratio [OR] = 1.9; 95% confidence interval [CI], 1.1-3.3) and cigarette smoking at any time (OR = 1.8; 95% CI, 1.1-3.0) were significantly associated with presence of multiple aneurysms. In the multivariate analysis, cigarette smoking at any time (OR = 1.7; 95% CI, 1.1-2.8) and female gender (OR = 2.1; 95% CI 1.2-3.5) remained significantly associated with multiple aneurysms. Hypertension, diabetes mellitus, and alcohol and illicit drug use were not significantly associated with presence of multiple aneurysms. CONCLUSION: Cigarette smoking and female gender seem to increase the risk for multiple aneurysms in patients predisposed to intracranial aneurysm formation. Further studies are required to investigate the mechanism underlying the association between cigarette smoking and intracranial aneurysm formation. 相似文献
109.
110.
WC Buijs JG Tibben OC Boerman CF Molthoff LF Massuger EB Koenders CP Schijf JA Siegel FH Corstens 《Canadian Metallurgical Quarterly》1998,25(11):1552-1561
In this study the potential of intraperitoneal (i.p.) and intravenous (i.v.) administration of chimeric iodine-131-labelled MOv18 IgG for radioimmunotherapy was determined. The dosimetry associated with both routes of administration of cMOv18 IgG was studied in patients. Eight patients suspected of having ovarian carcinoma received 150 MBq 131I-cMOv18 IgG i.p. Blood and urine were collected and serial gamma camera images were acquired. Another group of four patients received 7.5 MBq 131I-cMOv18 IgG i.v. For all patients, tissue biopsies were obtained at surgery. Activity in the blood after i.p. administration was described by a bi-exponential curve with a mean uptake and elimination half-life of 6.9+/-3.2 h and 160+/-45 h, respectively. For i.v. infusion the mean half-life for the elimination phase was 103+/-12 h. Cumulative excretion in the urine was 17%+/-3% ID and 21%+/-7% ID in 96 h for i.p. and i.v. administration, respectively. Scintigraphic images after i.p. administration showed accumulation in ovarian cancer lesions, while all other tissues showed decreasing activity with time. Tumour uptake determined in the ovarian cancer tissue specimens ranged from 3.4% to 12.3% ID/kg for i.p. administration and from 3.6% to 5.4% ID/kg for i.v. administration. Dosimetric analysis of the data indicated that 1.7-4.3 mGy/MBq and 1.7-2.2 mGy/MBq can be guided to solid or ascites cells after i.p. and i.v. administration, respectively. Assuming that an absorbed dose to the bone marrow of 2 Gy will be dose limiting, a total activity of 4.1 GBq 131I-cMOv18 IgG can be administered safely via the i.p. route and 3.5 GBq via the i.v. route. At this maximal tolerated dose, a maximum absorbed dose to 1-g tumours in the peritoneal cavity of 18 and 8 Gy can be reached after i.p. and i.v. administration, respectively. For the i. p. route of administration, dose estimates for the tumour are even higher when the electron dose of the peritoneal activity is also taken into account: total doses to the tumour of 30 Gy and 22 Gy will be absorbed at the tumour surface and at 0.2 mm depth, respectively. In conclusion, therapeutic tumour doses can be achieved with 131I-cMOv18 IgG in patients with intraperitoneal ovarian cancer lesions with no normal organ toxicity. The i.p. route of administration seems to be preferable to i.v. administration. 相似文献